Knowledge (XXG)

Beacon Pharmaceuticals

Source 📝

312: 295: 278: 261: 24: 597: 669: 689: 694: 487: 674: 664: 564: 699: 270: 44: 377:. Beacon is public limited company listed in Dhaka & Chittagong stock exchange. About 2000 people are working in this company. 679: 556: 495: 40: 158: 36: 536: 94: 684: 162: 108: 388: 384: 177: 173: 357:
Beacon manufactures more than 200 generic drugs and 65 oncology products. Beacon is the first company in
469:(BML) is the exclusive global marketing & distribution partner of Beacon Pharmaceuticals Limited. 581: 86: 576: 98: 560: 90: 351: 72: 658: 374: 112: 80: 553: 460: 424: 249: 213: 517: 456: 452: 448: 436: 420: 400: 392: 245: 241: 237: 225: 209: 189: 181: 444: 416: 404: 396: 358: 287: 233: 205: 193: 185: 440: 432: 428: 229: 221: 217: 361:
to start export of cancer drugs. The company is exporting its products to
412: 408: 201: 197: 23: 615: 370: 366: 304: 141: 33:
may have been created or edited in return for undisclosed payments
647: 362: 598:"US' Gilead faces competition from Bangladesh's Beacon pharma" 334: 17: 638: 39:. It may require cleanup to comply with Knowledge (XXG)'s 380:
Beacon has introduced a number of global first generics.
383:
The company's commercially available products include
354:
company that develops generic version of medications.
329: 319: 302: 285: 268: 255: 169: 152: 136: 118: 104: 78: 68: 554:http://www.secbd.org/ProspectusOfBeaconPharma.pdf 537:"Beacon Pharma to invest Tk 290cr for expansion" 565:Securities and Exchange Commission (Bangladesh) 488:"Bangladesh begins export of anti-cancer drugs" 8: 670:Pharmaceutical companies established in 2006 63: 690:Biotechnology companies established in 2006 518:"Anti-cancer drugs now made in Bangladesh" 62: 695:Bangladeshi companies established in 2006 486:Chowdhury, Raihan M. (13 August 2012). 478: 675:Pharmaceutical companies of Bangladesh 665:Manufacturing companies based in Dhaka 535:Ahmed, Gazi Towhid (28 January 2015). 7: 35:, a violation of Knowledge (XXG)'s 14: 596:Rajagopal, Divya (27 July 2016). 577:"Beacon Pharmaceuticals Limited" 311: 310: 294: 293: 277: 276: 260: 259: 22: 1: 700:Companies in the DSE 30 Index 159:Mohammad Ebadul Karim Bulbul 124:; 18 years ago 716: 348:Beacon Pharmaceuticals PLC 64:Beacon Pharmaceuticals PLC 494:. Dhaka. Archived from 467:BEACON Medicare Limited 680:Life sciences industry 389:sofosbuvir/daclatasvir 385:velpatasvir/sofosbuvir 620:beaconmedicare.com.bd 492:The Financial Express 315:US$ 100 million (2021 281:US$ 27 million (2019) 264:US$ 56 million (2019) 45:neutral point of view 582:Dhaka Stock Exchange 298:US$ 4 million (2019) 524:. 23 February 2010. 321:Number of employees 65: 602:The Economic Times 559:2017-12-17 at the 498:on 25 August 2016 350:is a Bangladeshi 345: 344: 325:4,000 (2021) 61: 60: 707: 651: 650: 648:Official website 642: 641: 639:Official website 624: 623: 612: 606: 605: 593: 587: 586: 573: 567: 551: 545: 544: 532: 526: 525: 514: 508: 507: 505: 503: 483: 341: 338: 336: 314: 313: 307: 297: 296: 280: 279: 271:Operating income 263: 262: 132: 130: 125: 66: 56: 53: 41:content policies 26: 18: 715: 714: 710: 709: 708: 706: 705: 704: 685:Specialty drugs 655: 654: 646: 645: 637: 636: 633: 628: 627: 614: 613: 609: 595: 594: 590: 575: 574: 570: 561:Wayback Machine 552: 548: 534: 533: 529: 516: 515: 511: 501: 499: 485: 484: 480: 475: 333: 322: 303: 290: 273: 155: 148: 144: 128: 126: 123: 111: 83: 57: 51: 48: 43:, particularly 27: 12: 11: 5: 713: 711: 703: 702: 697: 692: 687: 682: 677: 672: 667: 657: 656: 653: 652: 643: 632: 631:External links 629: 626: 625: 607: 588: 568: 546: 541:The Daily Star 527: 522:The Daily Star 509: 477: 476: 474: 471: 352:pharmaceutical 343: 342: 331: 327: 326: 323: 320: 317: 316: 308: 300: 299: 291: 286: 283: 282: 274: 269: 266: 265: 257: 253: 252: 171: 167: 166: 156: 153: 150: 149: 146: 140: 138: 134: 133: 120: 116: 115: 106: 102: 101: 84: 79: 76: 75: 70: 59: 58: 30: 28: 21: 13: 10: 9: 6: 4: 3: 2: 712: 701: 698: 696: 693: 691: 688: 686: 683: 681: 678: 676: 673: 671: 668: 666: 663: 662: 660: 649: 644: 640: 635: 634: 630: 621: 617: 611: 608: 603: 599: 592: 589: 584: 583: 578: 572: 569: 566: 562: 558: 555: 550: 547: 542: 538: 531: 528: 523: 519: 513: 510: 497: 493: 489: 482: 479: 472: 470: 468: 464: 462: 458: 454: 450: 446: 442: 438: 434: 430: 426: 422: 418: 414: 410: 406: 402: 398: 394: 390: 386: 381: 378: 376: 375:Latin America 372: 368: 364: 360: 355: 353: 349: 340: 332: 328: 324: 318: 309: 306: 301: 292: 289: 284: 275: 272: 267: 258: 254: 251: 247: 243: 239: 235: 231: 227: 223: 219: 215: 211: 207: 203: 199: 195: 191: 187: 183: 179: 175: 172: 168: 164: 160: 157: 151: 143: 139: 135: 121: 117: 114: 113:Biotechnology 110: 109:Pharmaceutics 107: 103: 100: 96: 92: 88: 85: 82: 77: 74: 71: 67: 55: 46: 42: 38: 34: 31:This article 29: 25: 20: 19: 16: 619: 610: 601: 591: 580: 571: 549: 540: 530: 521: 512: 500:. Retrieved 496:the original 491: 481: 466: 465: 461:trelagliptin 425:cabozantinib 382: 379: 356: 347: 346: 335:beaconpharma 305:Total assets 137:Headquarters 69:Company type 49: 37:terms of use 32: 15: 457:tofacitinib 453:regorafenib 449:palbociclib 437:eltrombopag 421:baricitinib 401:daclatasvir 393:osimertinib 659:Categories 473:References 445:lenvatinib 417:brigatinib 405:sofosbuvir 397:crizotinib 359:Bangladesh 288:Net income 154:Key people 147:Bangladesh 99:BEACONPHAR 91:BEACONPHAR 604:. Mumbai. 502:11 August 441:ibrutinib 433:neratinib 429:dasatinib 246:Tofacinix 214:Cabozanix 210:Baricinix 81:Traded as 52:July 2019 557:Archived 413:axitinib 409:afatinib 238:Palbonix 234:Lenvanix 190:Daclavir 186:Crizonix 174:Sofosvel 170:Products 105:Industry 330:Website 256:Revenue 242:Regonix 230:Ibrutix 226:Elbonix 218:Dasanix 206:Brigaix 194:Soforal 178:Darvoni 127: ( 119:Founded 97::  89::  616:"Home" 459:, and 371:Europe 367:Africa 250:Wedica 248:, and 222:Hernix 202:Axinix 198:Afanix 182:Tagrix 73:Public 142:Dhaka 504:2016 373:and 363:Asia 337:.com 129:2006 122:2006 339:.bd 161:, ( 95:CSE 87:DSE 47:. 661:: 618:. 600:. 579:. 563:, 539:. 520:. 490:. 463:. 455:, 451:, 447:, 443:, 439:, 435:, 431:, 427:, 423:, 419:, 415:, 411:, 407:, 403:, 399:, 395:, 391:, 387:, 369:, 365:, 244:, 240:, 236:, 232:, 228:, 224:, 220:, 216:, 212:, 208:, 204:, 200:, 196:, 192:, 188:, 184:, 180:, 176:, 163:MD 145:, 93:, 622:. 585:. 543:. 506:. 165:) 131:) 54:) 50:(

Index


terms of use
content policies
neutral point of view
Public
Traded as
DSE
BEACONPHAR
CSE
BEACONPHAR
Pharmaceutics
Biotechnology
Dhaka
Mohammad Ebadul Karim Bulbul
MD
Sofosvel
Darvoni
Tagrix
Crizonix
Daclavir
Soforal
Afanix
Axinix
Brigaix
Baricinix
Cabozanix
Dasanix
Hernix
Elbonix
Ibrutix

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.